Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT04141553
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Mercy Health Muskegon
- Registry
-
NCT04141553
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04141553. Randomized; single masking; primary purpose treatment. Start 2019-12-01 (anticipated); primary completion 2021-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter
- Condition
- Atrial Fibrillation
- Condition
- Atrial Flutter
- Condition
- Rapid Ventricular Response
- Intervention (Drug)
- Diltiazem Injection
- Lead sponsor
- Mercy Health Muskegon
Record details
- Record id
cardio:ct-nct04141553- Content hash
2aafac6fc05d1379324df2aa827ae11f40661e6fa7840ae6a03144fd8216e1b2